Scarica l'app Stockscreener
311.95
1.33%
-4.22
Dopo l'orario di chiusura:
310.00
-1.95
-0.63%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché PODD Giù?
Forum
Previsione
Precedente Chiudi:
$316.17
Aprire:
$316.81
Volume 24 ore:
403.44K
Relative Volume:
0.66
Capitalizzazione di mercato:
$21.96B
Reddito:
$2.36B
Utile/perdita netta:
$236.10M
Rapporto P/E:
94.93
EPS:
3.286
Flusso di cassa netto:
$382.50M
1 W Prestazione:
-3.56%
1M Prestazione:
+1.04%
6M Prestazione:
+23.65%
1 anno Prestazione:
+35.29%
Intervallo 1D:
$311.50
$320.43
Intervallo di 1 settimana:
$311.50
$327.74
Portata 52W:
$227.03
$353.50
Insulet Corporation Stock (PODD) Company Profile
Nome
Insulet Corporation
Settore
Industria
Telefono
978-600-7000
Indirizzo
100 NAGOG PARK, ACTON, MA
Confronta PODD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PODD
Insulet Corporation
|
311.95 | 22.26B | 2.36B | 236.10M | 382.50M | 3.286 |
|
ABT
Abbott Laboratories
|
124.67 | 216.57B | 43.84B | 13.94B | 6.78B | 7.9979 |
|
BSX
Boston Scientific Corp
|
100.57 | 148.62B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
368.98 | 141.30B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
90.97 | 117.65B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
83.48 | 48.55B | 5.69B | 1.41B | 577.90M | 6.9828 |
Insulet Corporation Stock (PODD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-21 | Ripresa | Stifel | Buy |
| 2025-09-08 | Ripresa | Oppenheimer | Outperform |
| 2025-06-16 | Iniziato | Truist | Buy |
| 2025-05-30 | Iniziato | Goldman | Buy |
| 2025-05-13 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2025-04-29 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2025-03-06 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-11-06 | Iniziato | Bernstein | Outperform |
| 2024-05-30 | Iniziato | Redburn Atlantic | Buy |
| 2024-05-07 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2023-12-21 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2023-12-04 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2023-10-02 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-08-21 | Aggiornamento | Citigroup | Neutral → Buy |
| 2023-08-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2023-05-30 | Ripresa | Morgan Stanley | Equal-Weight |
| 2023-01-26 | Iniziato | Wolfe Research | Peer Perform |
| 2022-11-04 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2022-10-18 | Iniziato | Barclays | Equal Weight |
| 2022-10-12 | Iniziato | Jefferies | Hold |
| 2022-07-11 | Downgrade | Citigroup | Buy → Neutral |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-02-03 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2022-02-02 | Aggiornamento | UBS | Neutral → Buy |
| 2022-01-31 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2021-07-21 | Ripresa | Cowen | Outperform |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-01 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2021-03-19 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2021-01-29 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-12-16 | Downgrade | Citigroup | Buy → Neutral |
| 2020-07-28 | Iniziato | Wells Fargo | Overweight |
| 2020-04-24 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-03 | Iniziato | BofA/Merrill | Neutral |
| 2020-03-31 | Downgrade | Berenberg | Buy → Hold |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2019-12-10 | Iniziato | CFRA | Sell |
| 2019-10-23 | Iniziato | Stifel | Hold |
| 2019-10-18 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2019-10-14 | Downgrade | BTIG Research | Buy → Neutral |
| 2019-10-04 | Downgrade | UBS | Buy → Neutral |
| 2019-10-03 | Downgrade | Guggenheim | Buy → Neutral |
| 2019-08-06 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2019-06-10 | Downgrade | Northland Capital | Outperform → Market Perform |
| 2019-05-06 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2018-04-20 | Iniziato | Berenberg | Buy |
| 2018-02-22 | Reiterato | Barclays | Overweight |
| 2018-01-08 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2017-11-03 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2017-09-15 | Iniziato | Barclays | Overweight |
Mostra tutto
Insulet Corporation Borsa (PODD) Ultime notizie
RBC Capital Lifts Insulet (PODD) PT to $365 on Strong Momentum, Q3 Guidance Optimism - Insider Monkey
Multi asset correlation models including Insulet CorporationJuly 2025 Drop Watch & Reliable Price Breakout Alerts - newser.com
Why Insulet Corporation stock is rated strong buyJuly 2025 Pullbacks & Weekly Chart Analysis and Guides - newser.com
Ownership Capital B.V. Sells 36,689 Shares of Insulet Corporation $PODD - MarketBeat
Whalen Wealth Management Inc. Sells 1,789 Shares of Insulet Corporation $PODD - MarketBeat
Insulet Corp. Experiences Evaluation Revision Amid Strong Market Performance and Technical Indicators - Markets Mojo
Why Insulet Corporation (GOV) stock could break out in 2025M&A Rumor & Technical Pattern Based Signals - newser.com
Insulet Corporation $PODD Stake Boosted by Nisa Investment Advisors LLC - MarketBeat
Insulet Champions Workplace Inclusion for People with Diabetes with New Data and Tools Released for Diabetes Awareness Month - Caledonian Record
Why Insulet Corporation (GOV) stock could outperform next yearEarnings Summary Report & Long-Term Capital Growth Ideas - newser.com
Sector ETF performance correlation with Insulet CorporationShort Setup & Low Drawdown Momentum Ideas - newser.com
Is Insulet Corporation stock a buy before product launchesEarnings Growth Summary & Long-Term Safe Investment Plans - newser.com
Can Insulet Corporation stock sustain revenue growthWeekly Trend Summary & Daily Growth Stock Tips - newser.com
How institutional ownership impacts Insulet Corporation stockWeekly Gains Summary & Long-Term Capital Growth Ideas - newser.com
Will Insulet Corporation rebound enough to break evenPortfolio Gains Summary & Target Return Focused Stock Picks - newser.com
Why Insulet Corporation stock appeals to dividend seekersJuly 2025 Snapshot & Long-Term Safe Investment Ideas - Fundação Cultural do Pará
Why Insulet Corporation (GOV) stock stays resilientJobs Report & Weekly Momentum Stock Picks - newser.com
United States Insulin Pump Market Outlook and Company - GlobeNewswire
United States Insulin Pump Market Outlook and Company Analysis Report 2025-2033 Featuring Medtronic, Insulet, Tandem Diabetes Care, Roche, Ypsomed, Microtech Medical - Yahoo Finance
Advanced analytics toolkit walkthrough for Insulet CorporationQuarterly Market Summary & Safe Capital Allocation Plans - newser.com
Full technical analysis of Insulet Corporation stockOil Prices & Growth Focused Stock Reports - newser.com
Will Insulet Corporation stock deliver strong dividend growth2025 Earnings Impact & Expert Approved Momentum Trade Ideas - newser.com
How to interpret RSI for Insulet Corporation stock2025 Year in Review & Low Drawdown Momentum Ideas - newser.com
Y Intercept Hong Kong Ltd Buys Shares of 23,068 Insulet Corporation $PODD - MarketBeat
Sumitomo Mitsui Trust Group Inc. Increases Holdings in Insulet Corporation $PODD - MarketBeat
Asset Management One Co. Ltd. Has $9.36 Million Stock Holdings in Insulet Corporation $PODD - MarketBeat
How to monitor Insulet Corporation with trend dashboardsJuly 2025 Outlook & Weekly High Return Stock Opportunities - newser.com
Insulet’s New Study on Simplified Onboarding for Type 2 Diabetes Management: A Potential Game Changer - TipRanks
Will Insulet Corporation outperform the marketWeekly Trade Summary & Free AI Powered Buy and Sell Recommendations - newser.com
Insulet’s Omnipod 5 Study: A Real-World Evaluation of Diabetes Management - TipRanks
Insulet’s Omnipod 5 SA2.0 Study: A Leap in Diabetes Management - TipRanks
AustralianSuper Pty Ltd Buys 170,247 Shares of Insulet Corporation $PODD - MarketBeat
Why Insulet Corporation stock could outperform in 20252025 Bull vs Bear & Daily Volume Surge Signals - newser.com
Insulet Corporation Azioni (PODD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.25%
0.03%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):